Carregant...
Antitumor effect of FP3 in a breast cancer xenograft model
FP3 is a novel vascular endothelial growth factor (VEGF) blocker proposed to have antiangiogenic properties. Previous studies revealed that FP3 is a new promising agent for treating human choroidal neovascularization (CNV)-associated age-associated macular degeneration (AMD) and has an inhibitory ef...
Guardat en:
Autors principals: | , , , |
---|---|
Format: | Artigo |
Idioma: | Inglês |
Publicat: |
D.A. Spandidos
2013
|
Matèries: | |
Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3524272/ https://ncbi.nlm.nih.gov/pubmed/23251246 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/etm.2012.773 |
Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|